This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing the standard of care for treating women with hot flashes due to menopause and the use of Veozah (fezolinetant).

Ticker(s): ALPMY

Who's the expert?

Women's Healthcare of Illinois OB/GYN

  • OBGYN
  • Sees several new patients with hot flashes a week, large number of patients in 40+
  • Has several patients on Veozah and offers it on a regular basis.

Interview Goal
to discuss the current standard of care and the use of Veozah (fezolinetan) an oral medication for the treatment of moderate to severe vasomotor symptoms, or hot flashes, caused by menopause.

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.